drugset / Trial / NCT01355991

Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI

NCT01355991

RandomizedCrossoverOpen-labelTreatment

Summary

To determine the acute and chronic effects of a short course of treatment on spinal cord injured (SCI) individuals with either an anticholinergic agent (tiotropium) or with a β₂ agonist (Salmeterol) on: * Fraction of expired NO (FeNO) * Selected Biomarkers of inflammation in exhaled breath condensates (EBC) * Pulmonary function, as measured by pulmonary function tests and body plethysmography

Timeline

Start
2011-08
Primary completion
2016-03
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salmeterol Other / unclassified 50 ug Inhaled
Comparator Tiotropium Other / unclassified 18 ug Inhaled

Indications